Indication
Thymoma and Thymic Carcinoma
2 clinical trials
2 products
2 drugs
Clinical trial
A Randomized Phase III Study of Adjuvant Radiotherapy Versus Adjuvant Radiochemotherapy in Patients With Incomplete ResectionThymoma or Thymic CarcinomaStatus: Recruiting, Estimated PCD: 2024-12-01
Drug
CisplatinProduct
EtoposideClinical trial
Phase II Study of Octreotide Treatment of Advanced, Recurrent ThymomaStatus: , Estimated PCD: 2003-09-01
Product
OctreotideDrug
prednisone